Egg Embryo Metabolic Analysis for Early Gender and Viability Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the gender, viability, and developmental stage of avian embryos in eggs are inefficient, requiring late-stage development and often destructive, leading to unnecessary incubator capacity and male chick culling, and lack early-stage gender selection capabilities.
Innovation Solution
A process for detecting developmental markers such as sugars and amino acids in avian eggs during incubation, using non-destructive methods to determine gender, viability, and developmental stage through multivariate statistical analysis of allantoic fluid samples, allowing early selection and efficient incubation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If candling technique is used to determine embryo viability, then live embryos can be identified, but reliable results require the egg to have progressed to at least day 11 of development
Solution Approach 1:
The patent performs metabolic analysis at early incubation stages (day 3-6) by detecting amino acid concentrations in the allantoic fluid, rather than waiting for later stages. This preliminary detection of metabolic markers enables gender and viability determination before day 11, resolving the contradiction by advancing the measurement time point while maintaining accuracy through biochemical markers that are present early in development.
2Measurement precision
If late-stage embryo analysis is performed, then gender and viability can be determined, but incubator capacity must be twice as large as necessary
Solution Approach 1:
The patent enables gender determination at early incubation stages (day 3-6) by detecting amino acid concentration ratios in the allantoic fluid, allowing hatcheries to identify male and female embryos before incubation is complete. This preliminary gender identification allows for selective incubation of only desired genders, reducing incubator capacity requirements by approximately 50% while maintaining accurate gender determination.
3Ease of manufacture
If traditional incubation methods are used, then all eggs are incubated regardless of viability or gender, but this leads to unnecessary male chick culling and reduced hatchery efficiency
Solution Approach 1:
The patent implements preliminary metabolic analysis of the allantoic fluid at early incubation stages to determine both viability and gender before completing incubation. This allows hatcheries to selectively incubate only viable eggs of the desired gender, eliminating the need to culk male chicks and improving overall hatchery efficiency by approximately 50% while maintaining process simplicity through non-destructive sampling.
4Loss of information
If destructive examination methods are used to analyze embryos, then detailed information can be obtained, but the eggs cannot be used for hatching or vaccine production
Solution Approach 1:
The patent uses the allantoic fluid as an intermediary medium to obtain metabolic information about the embryo without directly examining or damaging the embryo itself. By analyzing amino acid concentrations in this fluid, comprehensive information about embryo viability and gender is obtained while the egg remains intact and suitable for subsequent hatching or vaccine production, thus preserving egg usage flexibility.
Data Source
AI summary
The present invention relates to a process for the non-destructive determination of gender, developmental stage and/or viability of an avian embryo in an egg, comprising (a) detecting at least a first developmental marker compound selected from sugars and/or amino acids, precursors and metabolites thereof in an egg at a time period of from the beginning of the incubation of the egg until the hatching; (b) measuring the amount of the at least first detected developmental marker compound, and (c) comparing the amount to a base line established for male and female, developmental stage of the embryo, and/or alive and deceased or non-developed embryo, to determine whether the embryo is viable, male and/or female, and/or the developmental stage of the embryo.